title: Regression of oral Kaposi's sarcoma after combination antiretroviral therapy.
authors.affiliation: Area of Pathology, School of Dentistry, Federal University of Uberlandia, Av. Pará, 1720, Campus Umuarama, Uberlandia, MG, 38400-902, Brazil.
authors.forename: J P S
authors.initials: JP
authors.lastname: Servato
authors.forename: A M
authors.initials: AM
authors.lastname: Loyola
authors.forename: P H R
authors.initials: PH
authors.lastname: Spini
authors.forename: T H
authors.initials: TH
authors.lastname: Spini
authors.forename: P R
authors.initials: PR
authors.lastname: de Faria
authors.forename: Sérgio Vitorino
authors.initials: SV
authors.lastname: Cardoso
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000473:pathology; D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D000480:Alkynes; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D048588:Benzoxazines / Q000627:therapeutic use; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D063065:Organophosphonates / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000473:pathology*; D000068698:Tenofovir
chemical_list: D000480:Alkynes; D044966:Anti-Retroviral Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D063065:Organophosphonates; D019259:Lamivudine; D000068698:Tenofovir; D000225:Adenine; C098320:efavirenz